Difference between revisions of "MRE Biomarker Ctte"
Jump to navigation
Jump to search
(7 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | :Co-chairs: | + | :Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD |
− | :Secretary: | + | :Secretary: Susan Weinmann |
− | + | :[[Media:QIBA MRE Roster.pdf|'''Roster''']] | |
==Project Snapshot== | ==Project Snapshot== | ||
Line 14: | Line 14: | ||
+ | |||
+ | ==MRE Profile Development== | ||
+ | *[[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf|'''MRE Profile, Draft: July 28, 2017''']] | ||
+ | *[[Media:Draft-MRE-QIBAProfile-2017-07-06.pdf|''MRE Profile, Initial Draft: July 6, 2017'']] | ||
+ | |||
==Working Documents== | ==Working Documents== | ||
− | |||
==Statistical Reference Documents== | ==Statistical Reference Documents== |
Revision as of 15:22, 15 September 2017
- Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
- Secretary: Susan Weinmann
- Roster
Project Snapshot
The MRE Biomarker Committee seeks to develop a quantitative Profile for MRE.
MRE Profile to be data-driven:
- focusing on the characterization of bias and precision in MRE measurement targets for achieving these measurements
- focusing on issues important to specific reproducibility
Meetings/Call Summaries